Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
Badham, Stephen P, Hutchinson, Claire V · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2013 · DOI
Quick Summary
Many people with ME/CFS report that their eyes feel slow and they struggle to follow moving objects. This was the first study to objectively test these complaints using eye-tracking equipment. Researchers compared eye movements in people with ME/CFS to healthy controls and found that while simple eye movements were similar between groups, people with ME/CFS had significant difficulty smoothly tracking a moving target—a task that requires sustained eye control.
Why It Matters
This pioneering study provides the first objective, laboratory-based evidence validating patients' long-reported visual tracking difficulties, moving beyond subjective complaint to measurable dysfunction. Identifying oculomotor biomarkers could potentially improve diagnostic accuracy and help clinicians better understand the neurobiological basis of ME/CFS. These findings open new avenues for using eye-tracking as a potential objective diagnostic tool for ME/CFS.
Observed Findings
Patients showed normal saccade latencies and error rates on both prosaccade and antisaccade tasks, with intact prosaccade accuracy comparable to controls.
Patients demonstrated significant impairment on antisaccade tasks requiring them to look opposite a visual target.
Patients showed marked impairment on smooth pursuit eye movement tasks requiring continuous tracking of moving objects.
The pattern suggests preservation of brief, reflexive eye movements but dysfunction in sustained tracking activity.
Inferred Conclusions
ME/CFS effects can be briefly overcome for simple, discrete saccadic movements, but sustained pursuit activity reveals underlying oculomotor dysfunction.
Smooth pursuit tracking deficits may represent a biomarker or diagnostic indicator of ME/CFS.
Eye movement abnormalities in ME/CFS appear selective, affecting continuous tracking more than discrete saccadic control.
Remaining Questions
Is smooth pursuit dysfunction a specific biomarker for ME/CFS, or does it occur in other post-viral or fatiguing conditions?
Do eye movement deficits correlate with severity of other ME/CFS symptoms or functional impairment?
What are the underlying neural mechanisms causing selective impairment of smooth pursuit while sparing saccadic control?
What This Study Does Not Prove
This study does not establish whether smooth pursuit dysfunction is specific to ME/CFS or whether it occurs across all ME/CFS severities. The cross-sectional design cannot determine whether eye movement dysfunction causes other ME/CFS symptoms or vice versa. The findings do not clarify the underlying neural mechanisms responsible for the observed oculomotor impairment.